Oriental Rise Holdings Bolsa (NASDAQ: ORIS)

Últimas noticias sobre Oriental Rise Holdings (NASDAQ:ORIS) Bolsa

Oriental Rise Holdings

Oriental Rise Holdings Ltd is a company who is an integrated supplier of tea products in Mainland China. Their major tea products include primarily-processed tea consisting of white tea and black tea, and refined white tea and black tea. Its business operations are vertically integrated, covering cultivation, processing of tea leaves and the sale of tea products to tea business operators (such as wholesale distributors) and end-user retail customers in Mainland China.

Oriental Rise Holdings Limited - Ordinary Shares

Oriental Rise Holdings Ltd

B. Riley Securities analyst Mayank Mamtani initiates coverage on Nektar Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NKTR#NASDAQ">NKTR</a>) with a Buy rating and announces Price Target of $4.

News

Price Target

Initiation

Analyst Ratings

NKTR

B. Riley Securities Initiates Coverage On Nektar Therapeutics with Buy Rating, Announces Price Target of $4

<ul>
<li>The Company now expects Med Tech net sales to grow in the range of 12% to 15%, an increase from 10% to 12%</li>
<li>The Company now expects Med Device net sales to be flat, a decrease from 1% to 3%</li>
<li>The Company continues to expect Gross margin to be approximately 52% to 53%</li>
<li>The Company now expects Adjusted EBITDA in the range of $1.0 to $3.0 million, an increase from the previous guidance of a loss of $2.5 million to $0. The updated guidance compares to a pro forma Adjusted EBITDA loss of $3.2 million in fiscal 2024</li>
</ul>

Earnings

Guidance

Health Care

General

ANGO

AngioDynamics Continues To Expect 2025 Net Sales Of $282M-$288M, Representing Growth Of Between 4.2%–6.4% Over Fiscal 2024 Pro Forma Revenue Of $270.7M Versus Consensus Of $283.86M

Air Lease Announced That It Delivered 18 New Aircraft From ALC's Orderbook And Sold 14 Aircraft To Third-party Buyers In The Q4 FY24

As of Jan. 8, 2025, two stocks in the financial sector could be flashing a real warning to investors who value momentum as a key criteria in their trading decisions.
The RSI is a momentum indicator, which compares a stock&#8217;s strength on days when prices go up to its strength on days when prices go down. When compared to a stock&#8217;s price action, it can give traders a better sense of how a stock may perform in the short term. An asset is typically considered overbought when the <a href="https://www.benzinga.com/topic/rsi">RSI is above 70</a>, according to <a href="https://pro.benzinga.com/">Benzinga Pro</a>. 
Here's the latest list of major overbought players in this sector.
<h3 class="wp-block-heading">Lesaka Technologies Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LSAK#NASDAQ">LSAK</a>)</h3>
<ul>
<li>Lesaka Technologies will release second quarter 2025 results after the closing bell on Feb. 5. The company's stock surged around 13% over the past six months and has a <a href="https://www.benzinga.com/quote/LSAK">52-week high of $5.60</a>.</li>
<li>RSI Value: 71.6&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</li>
<li>LSAK Price Action: Shares of Lesaka Technologies jumped 2.3% to close at $5.27 on Tuesday.</li>
</ul>
<h3 class="wp-block-heading">Central Plains Bancshares Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CPBI#NASDAQ">CPBI</a>)</h3>
<ul>
<li>On Oct. 28, Central Plains Bancshares adopted repurchase program of up to 200,000 shares of its common stock. The company's stock gained around 4% over the past month and <a href="https://www.benzinga.com/quote/CPBI">has a 52-week high</a> of $15.46.</li>
<li>RSI Value: 74.3</li>
<li>CPBI Price Action: Shares of Central Plains Bancshares gained 1.4% to close at $15.00 on Tuesday.</li>
</ul>
Read This Next: 
<ul>
<li>B<a href="https://www.benzinga.com/analyst-ratings/price-target/25/01/42846607/bank-of-new-york-mellon-earnings-are-imminent-these-most-accurate-analysts-revise-forecasts-ahead-of-earnings-call">ank of New York Mellon Earnings Are Imminent; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call</a></li>
</ul>

Short Ideas

Pre-Market Outlook

Markets

Trading Ideas

CPBI

LSAK

Top 2 Financial Stocks That May Fall Off A Cliff In January

Needham analyst Joseph Stringer maintains Stoke Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/STOK#NASDAQ">STOK</a>) with a Buy and maintains $22 price target.

STOK

Needham Maintains Buy on Stoke Therapeutics, Maintains $22 Price Target

Morgan Stanley analyst Alex Poon upgrades NetEase (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NTES#NASDAQ">NTES</a>) from Equal-Weight to Overweight and raises the price target from $90 to $108.

Upgrades

NTES

Morgan Stanley Upgrades NetEase to Overweight, Raises Price Target to $108

<figure class="table"> 
<table>
<tbody>
<tr>
<td colspan="2" rowspan="1">Second Quarter Fiscal 2025 Financial Outlook</td>
</tr>
<tr>
<td colspan="1" rowspan="1">ADS Growth (YoY)</td>
<td colspan="1" rowspan="1">(5.0)% - (3.0)%</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Adjusted Operating Margin1</td>
<td colspan="1" rowspan="1">6.5% - 7.5%</td>
</tr>
</tbody>
</table>
</figure>

MSC Industrial Projects Q2 Fiscal 2025 ADS Decline Of 3%-5% And Operating Margin Of 6.5%-7.5%

<a href="https://www.wsj.com/articles/amd-invests-in-drug-discovery-company-absci-in-push-to-sell-ai-chips-ba9ef2b1?mod=Searchresults_pos1&amp;page=1" title="https://www.wsj.com/articles/amd-invests-in-drug-discovery-company-absci-in-push-to-sell-ai-chips-ba9ef2b1?mod=Searchresults_pos1&amp;page=1">https://www.wsj.com/articles/amd-invests-in-drug-discovery-company-absci-in-push-to-sell-ai-chips-ba9ef2b1?mod=Searchresults_pos1&amp;page=1</a>

ABSI

The Wall Street Journal Reported Advanced Micro Devices Invests $20M n Drug-Discovery Startup Absci

On Monday, Dell Technologies Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DELL#NYSE">DELL</a>) announced a major rebranding of its personal computers, aiming to boost sales by adopting a simplified naming strategy similar to Apple Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AAPL#NASDAQ">AAPL</a>).
What Happened: The company has decided to retire long-standing product names like &#8220;XPS&#8221; and &#8220;Inspiron&#8221; in favor of a streamlined approach centered around the Dell name.
The rebranding is part of Dell&#8217;s strategy to make its products more appealing and less confusing for consumers. The new lineup will feature three tiers: Dell, Dell Pro, and Dell Pro Max, echoing Apple&#8217;s naming conventions.
See Also: <a href="https://www.benzinga.com/tech/25/01/42838231/jensen-huang-unveils-3000-personal-ai-supercomputer-the-size-of-a-small-book-it-runs-the-entire-nvidia-ai-stack">Jensen Huang Unveils $3000 ‘Personal AI Supercomputer' The Size Of A Small Book: ‘It Runs The Entire Nvidia AI Stack'</a>
The rebranding is also part of a broader effort to encourage PC upgrades, with AI-optimized systems and the end of support for Microsoft Corp.&#8217;s (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MSFT#NASDAQ">MSFT</a>) Windows 10 as potential catalysts.
Notably, Dell&#8217;s gaming brand, Alienware, will not be affected by the rebranding. The new Dell-branded devices will incorporate neural processing units to improve AI capabilities.
Subscribe to the <a href="https://bztechtrends.beehiiv.com/subscribe">Benzinga Tech Trends newsletter</a> to get all the latest tech developments delivered to your inbox.
Why It Matters: In November 2024, Dell announced earnings of $2.15 per share for the third quarter, surpassing the analyst consensus estimate of $2.05.
However, the <a href="https://www.benzinga.com/news/earnings/24/11/42201885/dell-technologies-shares-drop-after-q3-revenue-misses-estimates-details">company's quarterly revenue</a> totaled $24.37 billion, falling short of the expected $24.65 billion, though it represented a growth from the $22.25 billion recorded during the same quarter last year.
In the third quarter of 2024, Dell&#8217;s share of global PC shipments dropped to 15.7%, down from 16.7% in the previous quarter. The company remains the third-largest PC vendor worldwide, trailing behind Lenovo and HP, according to Statista.
Price Action: Dell's stock fell by 2.72% on Tuesday, ending the day at $121.27. However, the stock bounced back in Wednesday's pre-market session, increasing by 1.3% to $122.85, according to <a href="https://benzinga.grsm.io/lxquj26b2sag">Benzinga Pro data</a>.
Check out more of Benzinga's Consumer Tech coverage by <a href="https://www.benzinga.com/topic/consumer-tech">following this link</a>.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/trading-ideas/technicals/25/01/42827345/nvidia-soars-amd-stalls-ai-race-heats-up-at-ces-2025">Nvidia Soars, AMD Stalls: AI Race Heats Up At CES 2025</a></li>
</ul>
Disclaimer: This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.
Photo courtesy: Shutterstock

Tech

AAPL

DELL

MSFT

Dell Simplifies PC Lineup With Apple-Like Branding: XPS, Inspiron Brands Are Gone For Good

Goldman Sachs analyst Alex Scott upgrades Travelers Companies (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TRV#NYSE">TRV</a>) from Sell to Buy and announces $278 price target.

Goldman Sachs Upgrades Travelers Companies to Buy, Announces $278 Price Target

MSC Industrial Direct Co (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MSM#NYSE">MSM</a>) reported quarterly earnings of $0.86 per share which beat the analyst consensus estimate of $0.73 by 17.81 percent. This is a 31.2 percent decrease over earnings of $1.25 per share from the same period last year. The company reported quarterly sales of $928.500 million which beat the analyst consensus estimate of $904.604 million by 2.64 percent. This is a 2.67 percent decrease over sales of $953.969 million the same period last year.

Earnings Beats

MSC Industrial Direct Co Q1 2025 Adj. EPS $0.86 Beats $0.73 Estimate, Sales $928.500M Beat $904.604M Estimate

Needham analyst Gil Blum maintains Generation Bio (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GBIO#NASDAQ">GBIO</a>) with a Buy and lowers the price target from $10 to $8.

GBIO

Needham Maintains Buy on Generation Bio, Lowers Price Target to $8

GTLS

Chart Industries Announce Its Signing Of A Global Master Goods And Services Agreement With ExxonMobil

Goldman Sachs analyst Robert Cox downgrades Fidelis Insurance Hldgs (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FIHL#NYSE">FIHL</a>) from Neutral to Sell and lowers the price target from $21 to $16.

Downgrades

FIHL

Goldman Sachs Downgrades Fidelis Insurance Hldgs to Sell, Lowers Price Target to $16

AngioDynamics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ANGO#NASDAQ">ANGO</a>) reported quarterly losses of $(0.04) per share which beat the analyst consensus estimate of $(0.11) by 63.64 percent. The company reported quarterly sales of $73.02 million which beat the analyst consensus estimate of $70.93 million by 2.93 percent. This is a 9.17 percent increase over sales of $66.88 million the same period last year.

AngioDynamics Q2 2025 Adj EPS $(0.04) Beats $(0.11) Estimate, Sales $73.02M Beat $70.93M Estimate

Chardan Capital analyst Geulah Livshits maintains Immuneering (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IMRX#NASDAQ">IMRX</a>) with a Buy and maintains $13 price target.

IMRX

Chardan Capital Maintains Buy on Immuneering, Maintains $13 Price Target

Goldman Sachs analyst Alex Scott downgrades American Intl Gr (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AIG#NYSE">AIG</a>) from Buy to Neutral and lowers the price target from $83 to $79.

Goldman Sachs Downgrades American Intl Gr to Neutral, Lowers Price Target to $79

The most oversold stocks in the information technology sector presents an opportunity to buy into undervalued companies.
The RSI is a momentum indicator, which compares a stock&#8217;s strength on days when prices go up to its strength on days when prices go down. When compared to a stock&#8217;s price action, it can give traders a better sense of how a stock may perform in the short term. An asset is typically considered oversold when the <a href="https://www.benzinga.com/topic/rsi">RSI is below 30</a>, according to <a href="https://pro.benzinga.com/">Benzinga Pro</a>.
Here's the latest list of major oversold players in this sector, having an RSI near or below 30.
<h3 class="wp-block-heading">Monday.Com Ltd (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MNDY#NASDAQ">MNDY</a>)</h3>
<ul>
<li>On Jan. 6, Piper Sandler analyst Brent Bracelin maintained Monday.Com with an Overweight and lowered the price target from $350 to $345. The company' stock fell around 22% over the past month and has a <a href="https://www.benzinga.com/quote/MNDY">52-week low of $174.75</a>.</li>
<li>RSI Value: 27.1&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</li>
<li>MNDY Price Action: Shares of Monday.Com fell 4.9% to close at $225.36 on Tuesday.</li>
<li>Benzinga Pro's real-time newsfeed alerted to latest<a href="https://bzresearch.myclickfunnels.com/benzinga-pro-content-webinar-registration/?utm_source=BZprocontent010825&amp;t=be2bearmibe3na1"> MNDY news</a>. </li>
</ul>
<figure class="wp-block-image size-full is-resized"><a href="https://bzresearch.myclickfunnels.com/benzinga-pro-content-webinar-registration/?utm_source=BZprocontent010825&amp;t=be2bearmibe3na1"><img loading="lazy" decoding="async" width="900" height="830" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/08062421/image-38.png" alt="" class="wp-image-723682" style="width:608px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/08062421/image-38.png 900w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/08062421/image-38-300x277.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/08062421/image-38-768x708.png 768w" sizes="(max-width: 900px) 100vw, 900px" /></a></figure>
<h3 class="wp-block-heading">Microchip Technology Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MCHP#NASDAQ">MCHP</a>)&nbsp;&nbsp;&nbsp;</h3>
<ul>
<li>On Dec. 16, B of A Securities downgraded the stock from Neutral to Underperform and lowered its price target from $80 to $65. The company's stock fell around 7% over the past month and <a href="https://www.benzinga.com/quote/MCHP">has a 52-week low</a> of $55.29.</li>
<li>RSI Value: 28.4</li>
<li>MCHP Price Action: Shares of Microchip Technology fell 1.4% to close at $57.47 on Tuesday.</li>
<li>Benzinga Pro&#8217;s charting tool helped identify the trend in <a href="https://bzresearch.myclickfunnels.com/benzinga-pro-content-webinar-registration/?utm_source=BZprocontent010825&amp;t=be2bearmibe3na1">MCHP stoc</a>k. </li>
</ul>
<figure class="wp-block-image size-full is-resized"><a href="https://bzresearch.myclickfunnels.com/benzinga-pro-content-webinar-registration/?utm_source=BZprocontent010825&amp;t=be2bearmibe3na1"><img loading="lazy" decoding="async" width="923" height="848" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/08062448/image-39.png" alt="" class="wp-image-723685" style="width:546px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/08062448/image-39.png 923w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/08062448/image-39-300x276.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/08062448/image-39-768x706.png 768w" sizes="(max-width: 923px) 100vw, 923px" /></a></figure>
<h3 class="wp-block-heading">Western Digital Corp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WDC#NASDAQ">WDC</a>)</h3>
<ul>
<li>On Jan. 3, Mizuho analyst Vijay Rakesh maintained Western Digital with an Outperform and lowered the price target from $90 to $82.. The company's stock fell around 8% over the past month and has a 52-week l<a href="https://www.benzinga.com/quote/WDC">ow of $48.96</a>.</li>
<li>RSI Value: 29.6</li>
<li>WDC Price Action: Shares of Western Digital fell 1.2% to close at $64.87 on Tuesday.</li>
<li>Benzinga Pro&#8217;s signals feature notified of a potential breakout in <a href="https://bzresearch.myclickfunnels.com/benzinga-pro-content-webinar-registration/?utm_source=BZprocontent010825&amp;t=be2bearmibe3na1">WDC shares</a>. </li>
</ul>
<figure class="wp-block-image size-full is-resized"><a href="https://bzresearch.myclickfunnels.com/benzinga-pro-content-webinar-registration/?utm_source=BZprocontent010825&amp;t=be2bearmibe3na1"><img loading="lazy" decoding="async" width="887" height="837" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/08062542/image-40.png" alt="" class="wp-image-723686" style="width:581px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/08062542/image-40.png 887w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/08062542/image-40-300x283.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/08062542/image-40-768x725.png 768w" sizes="(max-width: 887px) 100vw, 887px" /></a></figure>
Read This Next: 
<ul>
<li><a href="https://www.benzinga.com/analyst-ratings/price-target/25/01/42846607/bank-of-new-york-mellon-earnings-are-imminent-these-most-accurate-analysts-revise-forecasts-ahead-of-earnings-call">Bank of New York Mellon Earnings Are Imminent; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call</a></li>
</ul>

Long Ideas

MCHP

MNDY

Top 3 Tech Stocks That May Rocket Higher This Quarter

Wells Fargo analyst Michael Sison upgrades RPM Intl (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RPM#NYSE">RPM</a>) from Equal-Weight to Overweight and raises the price target from $134 to $140.

Wells Fargo Upgrades RPM Intl to Overweight, Raises Price Target to $140

Evercore ISI Group analyst Thomas Gallagher upgrades Globe Life (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GL#NYSE">GL</a>) from In-Line to Outperform and raises the price target from $132 to $143.

Evercore ISI Group Upgrades Globe Life to Outperform, Raises Price Target to $143

U.S. IPO Weekly Recap: Small Issuers Keep The October IPO Market Moving

Self-driving startup Pony.ai of China filed for an IPO in the U.S. this week. Meanwhile, four companies -- Springview Holdings, Oriental Rise Holdings, PTL Limited, and Samfine Creation Holdings Group -- saw their stocks open for trading.

Self-Driving Startup Pony.ai Files For U.S. IPO

15:27 EST Oriental Rise (ORIS) Holdings Ltd trading halted, volatility trading pause Published first on TheFly – the ultimate source for real-time,...

Oriental Rise Holdings Ltd trading halted, volatility trading pause

15:37 EST Oriental Rise (ORIS) Holdings Ltd trading resumes Published first on TheFly – the ultimate source for real-time, market-moving breaking f...

Oriental Rise Holdings Ltd trading resumes

12:33 EST Oriental Rise (ORIS) Holdings Ltd trading resumes Published first on TheFly – the ultimate source for real-time, market-moving breaking f...

12:23 EST Oriental Rise (ORIS) Holdings Ltd trading halted, volatility trading pause Published first on TheFly – the ultimate source for real-time,...

09:35 EST Oriental Rise (ORIS) Holdings Ltd trading resumes Published first on TheFly – the ultimate source for real-time, market-moving breaking f...

09:30 EST Oriental Rise (ORIS) Holdings Ltd trading halted, volatility trading pause Published first on TheFly – the ultimate source for real-time,...

Catalyst Watch:  Goldman Sachs finance conference; Adobe, CostCo earnings

Oracle And Broadcom Are Top Names Reporting Results As Earning Season Winds Down

ADBE

ADSK

AKAM

AVGO

BIOA

CASY

CGGJ

CIEN

CLRB

CNSP

COIN

COST

CSCO

CSGP

CURX

DGLY

ETSY

FERG

GDDY

GOOG

GOOGL

GRDN

HMBL

IMPP

INGM

LGCY

LGND

MTCH

NDSN

NTNX

NVDA

OLLI

ORCL

ORIS

PLAY

PONY

PSNY

PTLE

PZZA

QCOM

RILY

RVNC

SEAT

SFHG

SHAK

SMAR

SPHL

SPIR

TTAN

TWLO

UBER

UNFI

ZYME

IPOs

Press Releases

Oriental Rise Holding Limited Announces Pricing of Initial Public Offering

Oriental Rise Holding Limited Announces Closing of Initial Public Offering

Oriental Rise Holding Limited Announces Full Exercise of Underwriter's Over-Allotment Option

Forafric Global

Branchout Food

Barfresh Food Group

Bridgford Foods Corporation - Common Stock

Bridgford Foods

Borealis Foods Inc. - Class A Common Shares

Borealis Foods

Better Choice Co

Beyond Meat

Australian Oilseeds Holdings Limited - Ordinary Shares

Australian Oilseeds Hldgs

DDC Enterprise Limited Class A Ordinary Shares

DDC Enterprise

Farmer Bros

CIMG

Coffee Holding Co

Laird Superfood

Lifeway Foods

Mama`s Creations

Moolec Science

Oatly Group AB - American Depositary Shares

Oatly Group

TDH Hldgs

Planet Green Holdings

Rocky Mountain Chocolate Factory, Inc. - Common Stock

Rocky Mountain Chocolate

Sow Good

Steakholder Foods Ltd. - American Depositary Shares

Steakholder Foods

Top Wealth Group Holding Limited - Ordinary Shares

Top Wealth Group

Wing Yip Food Holdings Group Limited - American Depositary Shares

Comments

Oriental Rise Holdings

Noticias

Últimas noticias sobre Oriental Rise Holdings (NASDAQ:ORIS) Bolsa

La gente también mira

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL